[Expression of muscarinic acetylcholine receptor-1 in human retinal pigment epithelium]

Li-Hua Zhang1, Dong-Sheng Yan, Xiang-Tian Zhou

  • 1School of Optometry and Ophthalmology, Wenzhou Medical College, Zhejiang 325003, China.

Abstract

Insights

Muscarinic acetylcholine receptor 1 (M1 receptor) is present in human retinal pigment epithelium (RPE). This receptor is crucial for RPE function and may play a role in myopia development.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Cell Biology

Context:

  • The human retinal pigment epithelium (RPE) plays a vital role in maintaining retinal health and function.
  • Muscarinic acetylcholine receptors (mAChRs) are implicated in various physiological processes, but their presence and specific roles in RPE are not fully elucidated.
  • Myopia development is a growing concern, and understanding its underlying mechanisms is critical.

Purpose:

  • To identify the presence and localization of the muscarinic acetylcholine receptor 1 (M1 receptor) in human RPE cells.
  • To investigate the role of the M1 receptor in maintaining RPE function.
  • To explore the potential involvement of the M1 receptor in the occurrence and development of myopia.

Summary:

  • The study utilized reverse transcription-polymerase chain reaction (RT-PCR) and immunocytochemistry to detect M1 receptor mRNA and protein in cultured human RPE cells.
  • Results confirmed the expression of M1 receptor at both mRNA and protein levels in human RPE.
  • The M1 receptor was found to be important for RPE function, and its antagonism showed potential in delaying myopia progression.

Impact:

  • This research establishes the presence of M1 receptors in human RPE, highlighting a novel target for understanding RPE physiology.
  • Findings suggest that M1 receptor activity is linked to RPE function and may influence the development of myopia.
  • The study opens avenues for therapeutic strategies targeting M1 receptors to manage or prevent myopia progression.

Related Concept Videos

Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
Cholinergic Receptors: Nicotinic01:15

Cholinergic Receptors: Nicotinic

Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Direct-Acting Cholinergic Agonists: Pharmacological Actions00:59

Direct-Acting Cholinergic Agonists: Pharmacological Actions

Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
Parasympathetic Signaling01:30

Parasympathetic Signaling

Parasympathetic signaling plays a crucial role in regulating various physiological processes. It involves the release of acetylcholine (ACh) by parasympathetic neurons, which can have localized and short-lived effects. The majority of ACh released is rapidly inactivated at the synapse by the enzyme acetylcholinesterase (AChE), which hydrolyzes Ach into choline and acetate. Additionally, the tissue cholinesterase deactivates any ACh diffusing into the surrounding tissues.
The effects of...